Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
125947602 | 12594760 | 2 | F | 201503 | 20160831 | 20160726 | 20160912 | EXP | US-ELI_LILLY_AND_COMPANY-US201607005518 | ELI LILLY AND CO | 50.32 | YR | M | Y | 82.46000 | KG | 20160912 | MD | US | US |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
125947602 | 12594760 | 1 | PS | HUMALOG | INSULIN LISPRO | 1 | Subcutaneous | UNK, UNKNOWN | 20563 | 40 | IU | INJECTION | TID | ||||||
125947602 | 12594760 | 2 | SS | ALEVE | NAPROXEN SODIUM | 1 | Unknown | UNK, UNKNOWN | U | U | 0 | ||||||||
125947602 | 12594760 | 3 | SS | DEPO TESTOSTERONE | TESTOSTERONE | 1 | Intramuscular | UNK, UNKNOWN | U | U | 0 | 1 | ML | BIW | |||||
125947602 | 12594760 | 4 | C | LANTUS | INSULIN GLARGINE | 1 | Unknown | 60 U, BID | U | 0 | 60 | IU | BID | ||||||
125947602 | 12594760 | 5 | C | COREG | CARVEDILOL | 1 | Oral | 12.5 MG, BID | U | 0 | 12.5 | MG | TABLET | BID | |||||
125947602 | 12594760 | 6 | C | CATAPRES /00171101/ | CLONIDINE | 1 | Oral | 0.1 MG, BID | U | 0 | .1 | MG | TABLET | BID | |||||
125947602 | 12594760 | 7 | C | NEURONTIN | GABAPENTIN | 1 | Oral | 300 MG, QD | U | 0 | 300 | MG | CAPSULE | QD | |||||
125947602 | 12594760 | 8 | C | APIDRA | INSULIN GLULISINE | 1 | Subcutaneous | 40 U, AFTER DINNER | U | 0 | 40 | IU | INJECTION | ||||||
125947602 | 12594760 | 9 | C | PRINIVIL | LISINOPRIL | 1 | Oral | 20 MG, BID | U | 0 | 20 | MG | TABLET | BID | |||||
125947602 | 12594760 | 10 | C | OXYCONTIN | OXYCODONE HYDROCHLORIDE | 1 | Oral | 15 MG, PRN | U | 0 | 15 | MG | |||||||
125947602 | 12594760 | 11 | C | PERCOCET /00446701/ | ACETAMINOPHENOXYCODONE HYDROCHLORIDEOXYCODONE TEREPHTHALATE | 1 | Oral | 1 DF, PRN | U | 0 | 1 | DF | TABLET | ||||||
125947602 | 12594760 | 12 | C | PROTONIX /00661201/ | OMEPRAZOLE | 1 | Oral | 40 MG, BID | U | 0 | 40 | MG | TABLET | BID | |||||
125947602 | 12594760 | 13 | C | ZOCOR | SIMVASTATIN | 1 | Oral | 40 MG, QD | U | 0 | 40 | MG | TABLET | QD |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
125947602 | 12594760 | 1 | Type 2 diabetes mellitus |
125947602 | 12594760 | 2 | Product used for unknown indication |
125947602 | 12594760 | 3 | Product used for unknown indication |
125947602 | 12594760 | 10 | Pain |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
125947602 | 12594760 | OT |
125947602 | 12594760 | HO |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
125947602 | 12594760 | Abdominal distension | |
125947602 | 12594760 | Anaemia | |
125947602 | 12594760 | Carcinoid tumour of the small bowel | |
125947602 | 12594760 | Dehydration | |
125947602 | 12594760 | Diabetes mellitus inadequate control | |
125947602 | 12594760 | Diabetic ketoacidosis | |
125947602 | 12594760 | Drug dose omission | |
125947602 | 12594760 | Gastric haemorrhage | |
125947602 | 12594760 | Hypogonadism | |
125947602 | 12594760 | Hypophagia | |
125947602 | 12594760 | Ileal ulcer | |
125947602 | 12594760 | Intestinal polyp | |
125947602 | 12594760 | Malaise | |
125947602 | 12594760 | Pancreatitis acute | |
125947602 | 12594760 | Renal failure | |
125947602 | 12594760 | Renal hypertension | |
125947602 | 12594760 | Vomiting |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
---|---|---|---|---|---|---|
125947602 | 12594760 | 1 | 1998 | 0 |